AI assistant
Sending…
LIGAND PHARMACEUTICALS INC — Director's Dealing 2021
Jul 15, 2021
31289_dirs_2021-07-14_7d7327a5-39c0-453d-9d95-dcd59a085548.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2021-07-12
Reporting Person: Cochran Jennifer R. (Director)
More from LIGAND PHARMACEUTICALS INC
Proxy Solicitation & Information Statement
2026
May 18
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
May 1
Major Shareholding Notification
2026
May 1
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 27
Regulatory Filings
2026
Apr 27
Annual Report
2026
Apr 21